Company profile
DenovAI Biotech company profile
DenovAI is revolutionizing biologics discovery with a Gen AI-Physics platform for the de-novo design of therapeutic proteins, including antibodies and miniproteins. DenovAI’s cutting-edge technology accelerates drug discovery timelines and addressing unmet medical needs with accurately designed molecules.
Business identity
- Website
- https://denovai.com
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2023-01-01, Year
Headquarters
- Headquarters
- Reẖovot, Central District, Israel
- Postal code
- 7670104
- Country code
- IL
- Continent
- Asia